Article
Expression of CD44 variants and its association with survival in pancreatic cancer.
Japanese journal of cancer research : Gann - 1 Oct 1998
Gotoda T, Matsumura Y, Kondo H, Saitoh D, Shimada Y, Kosuge T, Kanai Y, Kakizoe T
Abstract excerpt
Since the CD44 variant 6(v6) molecule has been noted as a marker for tumor metastasis and prognosis in several tumors, we examined whether or not v6 is a useful marker for evaluating the prognosis of pancreatic cancer patients. In addition, we attempted to assess the clinicopathological implicati...
Topics
- Antigens, CD
- Biomarkers, Tumor
- Exons
- Female
- Follow-Up Studies
- Genetic Variation
- Humans
- Hyaluronan Receptors
- Immunohistochemistry
- Lymphatic Metastasis
- Male
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Neoplasm Staging
- Pancreas
- Pancreatic Neoplasms
- Probability
- Prognosis